Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct;41(10):e15952.
doi: 10.1111/echo.15952.

Benefit of Interventional Septal Reduction for Hypertrophic Cardiomyopathy: Looking for a Needle in a Haystack?

Affiliations

Benefit of Interventional Septal Reduction for Hypertrophic Cardiomyopathy: Looking for a Needle in a Haystack?

Olivier Piot et al. Echocardiography. 2024 Oct.
No abstract available

PubMed Disclaimer

References

    1. E. Arbelo, A. Protonotarios, J. R. Gimeno, et al., “ESC Scientific Document Group. 2023 ESC Guidelines for the Management of Cardiomyopathies,” European Heart Journal 44 (2023): 3503–3626.
    1. M. Y. Desai, A. Owens, K. Wolski, et al., “Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 56 Results From the VALOR‐HCM Randomized Clinical Trial,” JAMA Cardiology 8 (2023): 968–977.
    1. T. Lawrenz, D. Lawin, K. Radke, et al., “Acute and Chronic Effects of Endocardial Radiofrequency Ablation of Septal Hypertrophy in HOCM,” Journal of Cardiovascular Electrophysiology 32 (2021): 2617–2624.
    1. Q. Wu, Q. Liang, R. Wang, et al., “Transcoronary Radiofrequency Ablation: A Novel Septal Reduction Option for Hypertrophic Obstructive Cardiomyopathy,” JACC: Cardiovascular Interventions 16 (2023): 725–726.
    1. E. S. Shin, M. K. Chon, E. J. Jun, et al., “Septal Reduction Using Transvenous Intramyocardial Cerclage Radiofrequency Ablation: Preclinical Feasibility,” JACC: Basic to Translational Science 5 (2020): 988–998.

LinkOut - more resources